Essential Pharma Appoints Duncan Ferguson As Vice President, Commercial, Strengthening Management Team

Essential Pharma, a global company focused on medicines for niche and rare disease populations, has appointed Duncan Ferguson as Vice President, Commercial. Duncan will join the company where he will lead the commercial strategy across sales, marketing, product promotion, market access, and key customer and distribution relationships. With over 25 years of experience in the pharmaceutical industry, Duncan has a strong background in commercial strategy, market expansion, and business development. 

Emma Johnson, CEO of Essential Pharma, mentioned, “We are delighted to welcome Duncan to the Essential Pharma team. His deep commercial expertise and leadership experience will be instrumental in growing our portfolio of transformative medicines, enhance our rare disease expertise and support us in delivering more treatments to the patients that need them.”

Duncan Ferguson, VP Commercial of Essential Pharma, also stated, “I am thrilled to be joining Essential Pharma at such an exciting time in its journey. The Company’s commitment to delivering medicines to underserved patient populations is clear, and I look forward to working alongside the talented team to expand our commercial footprint and accelerate growth in order to bring more medicines to patients worldwide.”

He most recently served as Head of Partner Markets at Jazz Pharmaceuticals, overseeing strategic partnerships. Previously, he was General Manager for European Regional Markets at Jazz, where he launched an FDA and EMA-approved rare disease medicine. Duncan has also held senior roles at Aspen Pharma and LEO Pharma and started his career at Abbott Laboratories. Duncan’s expertise will support Essential Pharma’s continued growth and success in delivering medicines for underserved patient populations.